Google DeepMind VP John Jumper, a Nobel laureate for his work on AlphaFold, is leaving to join rival AI firm Anthropic. This follows another prominent researcher's departure to OpenAI.
FRONTEO is focusing on identifying target molecules for drug discovery using its AI engine "KIBIT," which analyzes論文 data to find unknown candidates. This accelerates a process that previously took years to mere days, addressing a key bottleneck in AI-driven drug development.
Diverse headlines covering tech (AI, robotics, space), politics (immigration, Vatican), and lifestyle, with no single overarching event.
